Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.95 |
| ▸ | CA2 | P00918 | 8/20 | 0.95 |
| ▸ | CA12 | O43570 | 5/20 | 0.95 |
| ▸ | CA7 | P43166 | 5/20 | 0.95 |
| ▸ | CA9 | Q16790 | 5/20 | 0.95 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylparaben SCHEMBL27901067 | 0.98 | CA1 (0.91) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL321534 | 0.98 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL4440 | 0.98 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL48757 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL21274302 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL1699480 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL8779118 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL16029235 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL2810862 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL6315862 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608929-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LyondellBasell Advanced Polymers Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12338390-B2 | Bridging particle and fluid loss control agent | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-06-24 | — | — | US | claimed |
| US-20240228859-A9 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024091462-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240132772-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-04-25 | — | — | US | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| CN-107635589-A | Essentially antimicrobial porous matrix composites and methods of making the same | 约翰·保罗·威尔逊 | 2018-01-26 | — | — | CN | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | claimed |
| EP-2101735-A2 | NANOPARTICULATE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF | Marinus Pharmaceuticals, Inc. (US) | 2009-09-23 | — | — | EP | claimed |
| US-20090004262-A1 | Nanoparticulate formulations and methods for the making and use therof | MARINUS PHARMACEUTICALS (US) | 2009-01-01 | — | — | US | claimed |
| WO-2008066899-A2 | NANOPARTICULATE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF | MARINUS PHARMACEUTICALS (US) | 2008-06-05 | — | — | WO | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| WO-2026090227-A1 | ORAL CARE STRIP | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4724590-A1 | ADENO-ASSOCIATED VIRUS FORMULATIONS | 4D Molecular Therapeutics Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |